HALOZYME THERAPEUTICS, INC. Convertible Notes Payable
Discontinued › Balance Sheet › Liabilities › Debt
us-gaap:ConvertibleNotesPayable · last filed 2023-02-21
- 2022-12-31: Convertible Notes Payable $1.51B.
- 2022-06-30: Convertible Notes Payable $878.62M.
- 2022-03-31: Convertible Notes Payable $877.64M.
- 2021-12-31: Convertible Notes Payable $876.67M.
| Period end | Convertible Notes Payable |
|---|---|
| 2022-12-31 | $1.51B 10-K · filed 2023-02-21 |
| 2022-06-30 | $878.62M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $877.64M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $876.67M 10-K · filed 2023-02-21 |
| 2021-09-30 | $875.71M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $874.74M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $873.77M 10-Q · filed 2021-05-10 |
| 2021-01-01 | $449.79M 10-K · filed 2022-02-22 |